“The CDSCO (Central Drugs Standard Control Organisation) has approved a vital randomised controlled trial on Covid-19 treatment with a biological called tocilizumab, in the first proposed multi-centre trial with the drug in India,” said Dr AS Soin, national lead investigator for the trial.from Industry-Economic Times
Read The Rest:economictimes...
